Introduction
Although the association between emphysema and pulmonary hypertension is well recognized, the precise mechanism of this association remains unclear (63) . We recently reported that tumor necrosis factor (TNF)-α overexpressing transgenic mice have age dependent chronic inflammation, severe alveolar enlargement, loss of elastic recoil, and physiologic changes consistent with emphysema (16). These mice also develop severe pulmonary hypertension and right ventricular hypertrophy similar to that observed in tight-skinned mice with emphysema and cor pulmonale.
(36) TNF-α has been reported as important in both the systemic (38) and pulmonary circulations.
(16, 27) Subtle, pulmonary vascular remodeling has been previously reported in mice with hypoxia induced pulmonary hypertension with thickening and neomuscularization of small resistance pulmonary arteries. (11, 23, 57) Several regulators of pulmonary vascular tone and structure have been implicated in the development of pulmonary arterial hypertension. Vascular endothelial growth factor (VEGF) and its receptors flk-1 and flt-1 (8, 50, 59 ), endothelin-1 (ET)-1 (19), and endothelial cell nitric oxide synthase (ecNOS) (11, 14, 18, 56, 57 ) have all been reported as important in modulating the development of pulmonary hypertension.
The importance of VEGF in the development of pulmonary hypertension is not clear. VEGF and its receptor (flk-1) are expressed in the characteristic plexiform lesion of human primary pulmonary hypertension (24, 61) and may play a role in the disordered angiogenesis found in the plexiform lesion of primary pulmonary hypertension. Endothelin-1 is increased in human pulmonary hypertension (58) and an endothelin-1 antagonist has recently been approved for the treatment of pulmonary hypertension. (54) However, modest overexpression of human ET-1 in mice was not associated with the development of pulmonary hypertension. (25) Inhaled nitric oxide (NO) has been used to attenuate pulmonary hypertension in humans with primary pulmonary hypertension (49), persistent pulmonary hypertension of the neonate (26), acute respiratory distress syndrome (52) , and in association with COPD. (41, 66) In animal studies, NO attenuates the development of hypoxic pulmonary hypertension. (30) In mice, loss of ecNOS leads to enhanced acute hypoxic vasoconstriction and susceptibility to chronic pulmonary hypertension following modest hypoxia and is associated with vascular remodeling (11, 56, 57 ) while overexpression of eNOS prevents hypoxia induced pulmonary hypertension. (5) Thus we hypothesized that chronic overexpression of TNF-α in mice leads to changes in expression of important modulators of pulmonary vascular tone and structure leading to pulmonary hypertension. To address the contributions of known modulators of pulmonary vascular tone and structure to the development of pulmonary hypertension in TNF-α transgenic mice, we measured expression of genes known to be important in the development of pulmonary hypertension in transgenic positive mice and negative littermate controls. Using morphometric analysis, we determined the extent of remodeling of the media and adventitial in transgenic mice. To determine if the pulmonary hypertension in transgenic mice was due to sustained vasoconstriction we tested the ability of inhaled nitric oxide (NO) to decrease pulmonary pressures. Additionally, to determine if left ventricular dysfunction was causing increased pulmonary pressures, we evaluated left ventricular function by echocardiography.
Materials and Methods
Animals SP-C/TNF-α transgenic mice overexpressing TNF-α were a kind gift of Y. Miyazaki (Department of Clinical Immunology, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan). The transgenic mice were crossed with C57BL/6 mice and bred in an animal facility documented to be free of murine specific pathogens. All transgenic mice were identified by PCR analysis of genomic DNA using primers reported previously. (40) Transgene negative littermates were used as controls. 
Morphometry
Morphometry of the pulmonary artery was performed according to established methods previously described with minor modifications. (2, 10, 22) Ten pulmonary arteries from mice age 6 to 8 months ranging 30-100 microns in size were digitally captured using Scion image software. The radius of pulmonary artery (r) in microns, thickness of smooth muscle layer (SMC), and thickness of perivascular fibrosis were measured by NIH Image Software Version 1.6. The area of the lumen of the vessel was determined followed by capturing of the total area encompassing the media and lumen and finally the area encompassing perivascular area, media, and lumen. The radius was then calculated for each measured area and used for analysis using the equation Area=πr 2 . Medial thickening (SMC/radius) was determined by measuring the radius of the external medial area and dividing by the internal radius of the artery. Adventitial fibrosis was determined by measuring the radius of perivascular fibrosis (collagen staining) and dividing by the internal radius of the artery plus media. Only round-shaped pulmonary arteries were chosen for morphometric analysis. 8 transgene positive and 6 transgene negative mice were used in these studies.
Cardiovascular physiology
In a separate group of animals age 6-8 months and after induction of anesthesia 
RNA extraction and Endothelin-1 Northern hybridization
Lung RNA was prepared by a guanidine isothiocyanate-cesium chloride (GITC) gradient procedure as previously described. (65) RNA samples were electrophoresed, transferred to a nylon membrane and hybridized with 32 P-labeled murine probes specific for murine endothelin (ET)-1. (6) Numbers of animals at age 1 and 6 months were 3 transgene positive and 3 transgene negative and at age 2.5 months was 3 transgene positive and 2 transgene negative.
RNase protection assay (RPA) for VEGF, flk-1, and flt-1 RPA was performed according to the method previously described. (65) Briefly, the probes of vascular endothelial growth factor (VEGF), (9) were separated on 1% agarose gels and visualized by ethidium bromide staining. Images were captured using a Scanner and band intensities were measured using NIH image software. The expression of ecNOS and iNOS were normalized to mimic. There were 5 animals in each group.
The primers were as follows:
antisense 5'-CCTTCTGCTCATTTTCCAGGTG-3'
Statistical analysis
Data are expressed as mean + standard error (SE). Data regarding hemodynamics and the effect of transgene and NO were analyzed using two-way ANOVA with Fisher post-hoc tests and p<0.05 considered significant. Analysis of ET-1, VEGF, flk-1, and flt-1 was also done using two-way ANOVA comparing effect of transgene and age. Analysis of ecNOS, iNOS, vessel morphometry, and echocardiographic measures were done with one-way ANOVA with p<0.05 considered significant. To determine if the pulmonary hypertension in TNF-α transgenic mice was associated with pulmonary vascular remodeling, we examined pulmonary arteries in fixed lungs using hematoxylin and eosin and connective tissue stains (sirus red and pentachrome for collagen). As shown in figure   2 , TNF-α transgenic mice age 6 to 8 months had perivascular fibrosis and adventitial thickening compared to transgene negative littermates. This was characterized by increased collagen deposition. (Figure 2 ) Digital morphometric analysis confirmed the adventitial thickening in transgenic mice (Table 1) . Additionally, there was a trend toward increased pulmonary arterial medial hypertrophy in transgenic compared to non-transgenic mice in hematoxylin and eosin staining. (Table 1) .
Results

Measurements
Echocardiography
To determine if the pulmonary hypertension in TNF-α transgenic mice was due to left ventricular dysfunction, echocardiography was performed on mice at age 6 months. Percent fraction shortening (%FS) of the left ventricle as a measurement of ventricular function in vivo was calculated.
Echocardiography demonstrated no differences of fractional shortening or LV wall thickness between transgenic positive and negative and littermates. (Table 2 ) In these studies, right ventricular size, function, or estimated pulmonary arterial pressure could be determined.
Messenger RNA profile
To determine the expression of important modulators of vascular growth and tone, mRNA levels of specific genes were determined. Lung ET-1 expression, as measured by Northern hybridization, likely did not play a role in the development of pulmonary hypertension. Additionally, in both rats and mice, iNOS is increased in the lung with hypoxia-induced pulmonary hypertension (13, 33, 51) and decreased iNOS may be important in the regulation of pulmonary vascular tone. (14) While TNF has been reported to induce iNOS expression, (60) and iNOS expression may increase with inflammation, we did not observe changes in iNOS message with TNF-α overexpression. Lastly, TNF itself may also act to enhance vasoconstriction in the pulmonary circulation. (7) Endothelin-1 (ET-1) a potent endogenous vasoconstrictor, is localized in smooth muscle cells of arteries and bronchioles, inflammatory cells, epithelium of bronchioles and pleura, and endothelium in the lung. ET-1 may contribute to collagen deposition in the lung (42) and contribute to perivascular fibrosis in pulmonary hypertension. (25, 35) ET-1 is also increased in the lungs of rats with spontaneous pulmonary hypertension at Denver altitude (55) and following chronic hypoxia. Consistent with our previous findings of normal LV weights in TNF-α overexpressing mice, LV wall thickness by echocardiography was also similar between transgene positive and negative mice.
While TNF-α is known to increase systemic resistance (38) , the fractional shortening was similar between the two groups confirming that LV function was not suppressed in TNF-α transgenic mice and was not likely the cause of pulmonary hypertension.
Human primary pulmonary hypertension is more common in young women but is not associated with earlier death when compared to afflicted men. (34) In the present study, while survival was decreased in all TNF-α transgenic compared to wild-type mice, female mice had a significantly higher mortality rate starting a 6 months of age. Elevated pulmonary artery pressure is associated with higher mortality in patients with emphysema (45) but in the present study, female mice did not have more severe pulmonary hypertension compared to male mice. Interestingly, there were fewer male transgenic mice born, consistent with observations in human familial pulmonary hypertension.
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-16 -A significant limitation of the present study is the small number of animals in some groups in which we measured gene expression for ET-1, VEGF, flk-1 and flt-1. While we did observe differences in VEGF and flk-1 but not flt-1, using increased numbers of animals might lead to a stronger conclusion regarding lung RNA levels in TNF-α transgenic mice. We are confident that the numbers of animals used to assess hemodynamics, vasoreactivity, and vascular remodeling were sufficient to support our conclusions.
In conclusion, overexpression of TNF-α resulted in severe pulmonary hypertension and 
